Your browser doesn't support javascript.
loading
SOX9 regulates ERBB signalling in pancreatic cancer development.
Grimont, Adrien; Pinho, Andreia V; Cowley, Mark J; Augereau, Cécile; Mawson, Amanda; Giry-Laterrière, Marc; Van den Steen, Géraldine; Waddell, Nicola; Pajic, Marina; Sempoux, Christine; Wu, Jianmin; Grimmond, Sean M; Biankin, Andrew V; Lemaigre, Frédéric P; Rooman, Ilse; Jacquemin, Patrick.
Afiliación
  • Grimont A; Université catholique de Louvain, de Duve Institute, Brussels, Belgium.
  • Pinho AV; Cancer Research Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia Australian Pancreatic Cancer Genome Initiative.
  • Cowley MJ; Cancer Research Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia Australian Pancreatic Cancer Genome Initiative.
  • Augereau C; Université catholique de Louvain, de Duve Institute, Brussels, Belgium.
  • Mawson A; Cancer Research Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia Australian Pancreatic Cancer Genome Initiative.
  • Giry-Laterrière M; Cancer Research Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia Australian Pancreatic Cancer Genome Initiative.
  • Van den Steen G; Université catholique de Louvain, de Duve Institute, Brussels, Belgium.
  • Waddell N; Australian Pancreatic Cancer Genome Initiative Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Queensland, Australia.
  • Pajic M; Cancer Research Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia Australian Pancreatic Cancer Genome Initiative St Vincent's Clinical School, University New South Wales, Australia.
  • Sempoux C; Department of Pathology, Université catholique de Louvain, Cliniques Universitaires St Luc, Brussels, Belgium.
  • Wu J; Cancer Research Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia Australian Pancreatic Cancer Genome Initiative St Vincent's Clinical School, University New South Wales, Australia.
  • Grimmond SM; Australian Pancreatic Cancer Genome Initiative Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, Queensland, Australia Wolfson Wohl Cancer Centre, University of Glasgow, Scotland, UK.
  • Biankin AV; Cancer Research Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia Australian Pancreatic Cancer Genome Initiative St Vincent's Clinical School, University New South Wales, Australia Wolfson Wohl Cancer Centre, University of Glasgow, Scotland, UK.
  • Lemaigre FP; Université catholique de Louvain, de Duve Institute, Brussels, Belgium.
  • Rooman I; Cancer Research Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia Australian Pancreatic Cancer Genome Initiative St Vincent's Clinical School, University New South Wales, Australia.
  • Jacquemin P; Université catholique de Louvain, de Duve Institute, Brussels, Belgium.
Gut ; 64(11): 1790-9, 2015 Nov.
Article en En | MEDLINE | ID: mdl-25336113
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático / Factor de Transcripción SOX9 / Receptores ErbB Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gut Año: 2015 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático / Factor de Transcripción SOX9 / Receptores ErbB Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gut Año: 2015 Tipo del documento: Article País de afiliación: Bélgica